.
Based on research carried out in populations occupationally exposed to DDT, it has also been suggested that DDT could play an important role in the etiology of pancreatic cancer (6) and leukemias (7) (8) (9) , as well as producing alterations in reproductive function, such as decreases in sperm count (10) , increases in the frequencies of preterm births (11, 12) and congenital malformations (13) , and decreases in the duration of lactation (14) .
Since the 1940s, DDT has been widely used throughout the world to combat agricultural pests, indoor insects, and in sanitation campaigns against malaria. At present its use has been totally banned in developed countries due to its persistence (low biodegradability), accumulation, and bioconcentration in lipid systems, including subcutaneous fat, breast tissue, brain, and adrenal glands (15, 16) . In Mexico, DDT application in sanitation campaigns against malaria began intermittently in 1956 and has continued systematically since 1960 (17) . Currently, the World Health Organization recommends the use of DDT for malarial outbreaks, although public health experts do not uniformly endorse this use. DDT targets adult insects and cannot kill larvae. Resistance of insects to DDT has occurred worldwide (18) .
Devastating and obvious effects of DDT on wildlife, such as endangerment of the American bald eagle and the peregrine falcon, were the grounds for the banning of DDT in the United States in the 1970s. As ecological levels of DDT have dropped in the United States, these previously endangered species have recovered (19) . More recently, a spill of the pesticide dicofol (which contained 10% DDT as an active ingredient) into Lake Apopka, Florida, has been tied to alterations in the sex ratio of alligators and increased defects in male alligators (20 (31) . During this same period, (1971) (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) , the capacity for DDT production in Mexico was 8000 tons annually, representing between 43% and 45% of the total national capacity for organochlorine pesticide production (29) .
The evolution of DDT production and consumption in Mexico between 1971 and 1991 is shown in Figure 1 . During the second part of the 1970s and the beginning of the 1980s, both production and consumption varied between 3400 and 4100 tons annually. Between 1982 and 1986, production and consumption decreased notably, almost to zero, although beginning in 1986 production began to grow again and consumption followed in 1987 (31).
The pronounced decrease in production and consumption of DDT observed during the first half of the 1980s in Mexico was principally due to two causes. First, a severe economic crisis affected Mexico in 1982, which resulted in a drastic drop in production and commercial activities in the country. Second, an international trend reduced the use of organochlorine pesticides, which were widely recognized to persist in the environment (32) . This trend resulted in restriction of DDT use in official Mexican sanitary campaigns, and therefore a notable decrease in demand and production of DDT.
As shown in Figure 2 , approximately 226,000 tons of DDT were used in the sprayed are shown (17 Figure 3 (17-33).
To illustrate the widespread production and marketing of DDT in Mexico, it should be noted that in 1987 there were Although the representativeness of the biological samples analyzed in some of these studies can be questioned, these studies suggest that there is a DDT accumulation gradient that is greater in tropical areas and/or regions with greater agricultural activity (Veracruz, Torreon, Ciudad Juarez). These data also show that inhabitants of urban areas are exposed to DDT (Torreon, Ciudad Juarez, Puebla, Veracruz, and Mexico City). (42) . Given the small sample size of most of these studies, they lacked the minimum power necessary to detect a difference, if one exists, between DDT levels in breast cancer patients and the corresponding levels in women without the disease. Another criticism has been the lack of control of confounding variables, principally parity, breastfeeding, and obesity, which are factors associated both with breast cancer incidence and accumulation or elimination of DDT from the body.
In addition to these limitations, other factors could account for some of the discrepancies in the results. For example, different tumor types may have distinct susceptibilities to xenoestrogens, so that estrogen-positive and -negative tumors may have different etiologies. In addition, levels of DDT or metabolites can be reported in either a lipid base or a wet base, thus affecting comparability across the studies.
In the only study that considered the presence of estrogenic receptors in patients with breast cancer (5), a highly significant difference was found between the levels of DDE in adipose tissue and serum in women with breast cancer (cases) and controls with benign breast disease (x DDE adipose tissue: 2732 ± 2749.9 pg/kg versus 765 ± 52.9 pg/kg, serum: 8.5 pg/l versus 3.5 pg/l). The groups of women compared were similar in terms of age, parity, and weight loss during the year before diagnosis. However, there was a greater prevalence of non-breastfeeding among cases (88.9% versus 76.5%). In spite of a small sample size (9 cases and 17 controls), the authors estimated an 8.9 times greater breast cancer risk in those women in whom DDE levels were above 1292 pg/kg in adipose tissue (5) .
In contrast, the epidemiological study with the largest sample size, carried out by Krieger et al. (24) , compared women with breast cancer and women without the disease among a cohort established between 1964 and 1971 . The 150 cases and controls consisted of 50 whites, 50 blacks, and 50 Asian-Americans. Although approximately 50% of the patients with breast cancer showed higher DDE levels, the difference between these levels and those of the control group was not statistically significant. However, when Asian-Americans were removed from the analysis, a two-to threefold excess of breast cancer was evident for blacks and whites with the highest levels of DDE in the sera. In addition, there was no information about breastfeeding or the proportion of estrogen-dependent breast tumors. Levels were not adjusted by total lipids, and no information of DDE levels in adipose tissue was provided, which is the best way to measure chronic DDT accumulation. This could have influenced the observed results (43) .
A similarly designed study, controlled for breastfeeding, found that breast cancer risk was 3.68 times greater in women with DDE serum levels of 19.1 ng/ml as compared to women with DDE serum levels of 2.0 ng/ml (4) . Another study reported that p,p'-DDE levels in adipose tissue of women with breast cancer are greater than corresponding levels in those with benign breast disease (3) .
In a study that compared only nine samples of adipose breast tissue from breast cancer patients and five adipose tissue samples from women who died in accidents, greater concentrations of o,p'-DDT were found in the women with breast cancer (2) . Finally, two more studies with the same type of limitations mentioned earlier did not report higher levels of DDT or its metabolites in women with breast cancer in comparison to women without the disease (26, 27) .
It is difficult to conclude whether exposure to DDT contributes to an increase in breast cancer. All of the recent studies have yielded evidence of a dose-response relationship, although these are subject to interpretation. There is an evident need for additional investigations that surmount the methodological limitations described here.
Conclusions
Many questions about DDT exposure and its potential impact on health are being researched at a number of levels. In terms of biomedical research, knowledge should be generated about the possible carcinogenic mechanisms of DDE in humans. Also, data are lacking about the levels of DDT accumulation in adipose tissue and serum, as well as rates of elimination of this compound in breast milk, in representative populations in developed and developing countries. Highrisk populations have been identified, principally in urban and agricultural areas. In Mexico there is a need to develop systematic and representative data on DDT contamination of foods, which will probably explain the high levels found in human samples.
Identification and assessment of less toxic and less persistent alternatives for controlling malaria and educational, population-based interventions to reduce DDT exposure both in the work environment and among the general population are also needed. These interventions could be directed toward promoting use of protective gear by workers and health education for populations not occupationally exposed.
The continuing epidemiological study being carried out by the National Institute of Public Health of Mexico, which seeks to evaluate the association between DDE accumulation levels in serum and adipose tissue and breast cancer in Mexican women, is promising in terms of its methodological characteristics. These characteristics indude sufficient statistical power (150 cases and 300 controls), a wide range of DDT exposure, control of confounding reproductive and dietary variables, assessment of DDT and DDE levels in lipid base, and information about estrogenic receptors in a subgroup of the cancer patients.
Efforts should continue to find alternatives to DDT while additional study results about its role in breast cancer are generated. Evidence on the long-term ecological consequences of DDT for wildlife are indisputable. The absence of clear-cut proof that DDT causes breast cancer should not be used as an excuse for further delays in phasing out this persistent, toxic organic pollutant. As many of the known causes of breast cancer cannot readily be altered, those causes that can be controlled become all the more important for public health.
